Equities

Oxford Biomedica PLC

Oxford Biomedica PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)205.00
  • Today's Change14.60 / 7.67%
  • Shares traded256.53k
  • 1 Year change-52.82%
  • Beta1.3536
Data delayed at least 20 minutes, as of Apr 18 2024 17:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2022202220212020
ASSETS
Cash And Short Term Investments14110947
Total Receivables, Net584251
Total Inventory139.526.91
Prepaid expenses3.983.212.63
Other current assets, total0.020.070.24
Total current assets216164108
Property, plant & equipment, net1347072
Goodwill, net0.66----
Intangibles, net1050.050.07
Long term investments------
Note receivable - long term5.013.613.61
Other long term assets------
Total assets460237184
LIABILITIES
Accounts payable145.267.78
Accrued expenses231412
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.300.854.48
Other current liabilities, total201328
Total current liabilities603352
Total long term debt1118.499.37
Total debt1149.3414
Deferred income tax5.59--0
Minority interest32----
Other liabilities, total488.109.36
Total liabilities2565071
SHAREHOLDERS EQUITY
Common stock484341
Additional paid-in capital380308258
Retained earnings (accumulated deficit)(223)(164)(186)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity205187113
Total liabilities & shareholders' equity460237184
Total common shares outstanding968682
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.